COFCO Capital's debut deal backs world's largest γ-PGA maker Shineking
What's the deal? COFCO Capital closed a strategic late-stage investment in Nanjing Shineking Biotech on October 27, marking its first bet on bio-agriculture and new food. The amount was not disclosed.
Who raised? Founded in 2010 in Nanjing and drawing on a research team at Nanjing Tech University, Shineking is the world's largest supplier of γ-polyglutamic acid (γ-PGA). It holds more than 60% of China's polyglutamic acid market, with a production line topping 10,000 tonnes and 1,500m³ of fermentation capacity.
What does it make? γ-PGA is bioactive, non-toxic, and fully biodegradable. It is used in agriculture for water retention and yield, in soil improvement, in personal-care moisturising, and as a food additive.
What's the money for? The round will mainly fund approval of sodium γ-polyglutamate as a new food raw material and expansion across agriculture and food markets. It also lays groundwork for entering food-grade applications.
What's the endgame? COFCO Capital plans to connect Shineking's biopolymer platform with COFCO Corporation's agricultural-input, food-processing, and nutrition businesses. The goal is to bridge the "last mile" in industrialising synthetic biology — moving it from the lab to the field and the food industry.
What could go wrong? Shineking's priorities hinge on regulatory clearance and proven demand. The deal is evidence of industrial backing, not yet proof that food-grade applications will scale.
The signal: Chinese synthetic-biology financings keep flowing to companies shifting from lab work to production — SynMetabio raised more than US$13.8M in July, and Weiyuan Synthetic Biology secured US$206.3M in May. COFCO's entry signals a corporate push to tie frontier biomanufacturing directly to agriculture and food supply chains.
Read more: news.agropages.com
Image credit: Generated with Gemini
